Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2023

Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2023

Obsessive-compulsive disorder (OCD) is a common, chronic, and long-lasting disorder in which a person experiences uncontrollable, reoccurring thoughts ("obsessions") and/or behaviors ("compulsions"). These obsessions and compulsions interfere with daily activities and cause significant distress.

There are five types of obsessive-compulsive disorders like contamination obsessions or cleaning compulsions, harm obsessions or cleaning compulsions, obsessions without compulsions, symmetry obsessions-ordering compulsions and Hoarding.

The most common causes of OCD are emotional trauma, history of abuse, low levels of serotonin, overactivity in areas the brain, changes in living situation, relationship problems and starting a new process or phase in life.

Signs of compulsions include Fear of touching objects others have touched, intense stress on observing inappropriateness, thoughts about shouting obscenities or acting inappropriately in public and voidance of shaking hands. Symptoms of obsessions include washing and cleaning, checking, counting, orderliness, following a strict routine and demanding reassurance.

Diagnosis of OCD involves psychological evaluation that includes discussing thoughts, feelings, symptoms and behavior patterns to determine if patient has obsessions or compulsive behaviors that interfere with quality of life. Healthcare provider may use criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association. Physical exam may be done to help rule out other problems that could be causing symptoms and to check for any related complications.

Obsessive-compulsive disorder subjects in mild condition used therapies are cognitive behavioral therapy (CBT) alone and in severe condition medications are antidepressants which are commonly prescribed to relieving anxiety.

Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Obsessive Compulsive Disorder treatment such as Troriluzole, PANZYGA, SYNP-101 and others. Key players involved in the development of therapies to treat Obsessive Compulsive Disorder are Biohaven Pharmaceuticals Inc, Cannabis Science Inc, Ceruvia Lifesciences, Octapharma, Omeros Corp and others. Two drugs are under late-stage Phase III clinical trials and one drug are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.

Report Highlights

Global Insight Service's, Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2023 report provides an overview of the Obsessive Compulsive Disorder (OCD) pipeline drugs. This report covers detailed insights on Obsessive Compulsive Disorder (OCD) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Obsessive Compulsive Disorder (OCD) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Reasons to Buy
Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.